PD-1 And PD-L1 Inhibitor Market Witnesses High Growth Owing To Increasing Adoption In Cancer Treatment
PD-1 and PD-L1 inhibitors are drugs used for immunotherapy treatment of various types of cancer including lung cancer, melanoma, kidney cancer, bladder cancer and Hodgkin's lymphoma. They work by blocking proteins called PD-1 and PD-L1 that help tumors hide from the immune system.
The global PD-1 and PD-L1 Inhibitor Market is estimated to be valued at US$ 39.83 Bn in 2023 and is expected...
0 Reacties
0 aandelen